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Abstract
Background: Sphingolipids – as suggested by the prefix in their name – are mysterious molecules, which play
surprisingly various roles in opposable cellular processes, like autophagy, apoptosis, proliferation and
differentiation. Recently they have been also recognized as important messengers in cellular signalling pathways.
More importantly, sphingolipid metabolism disorders were observed in various pathological conditions such as
cancer and neurodegeneration.
Results: Existing formal models of sphingolipids metabolism concentrates mostly on de novo ceramide synthesis
or restrict their focus to biochemical transformations of a particular subspecies. We propose first comprehensive
computational model of sphingolipid metabolism in human tissue. In contrast to previous approaches we
explicitly model compartmentalization what allows emphasizing the differences among individual organelles.
Conclusions: Presented here model was validated by means of recently proposed model analysis technics
allowing for detection of most sensitive and experimentally non-identifiable parameters and determination of
main sources of model variance. Moreover, we demonstrate the utility of the model for the study of molecular
processes underlying Alzheimer’s disease.
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1 Background
Sphingolipids (SL) are categorized as a class of complex lipids containing sphingoid base (SPH) [1].
Modification of this basic structure by amide-linked fatty acid or by phosphorylation gives rise to vast
family of bioactive sphingolipids like: ceramide (CER), ceramide-1-phosphate(C1P),
sphingosine-1-phosphate (S1P) or sphingomyelin (SM) [2,3]. Ceramide is known to be branching point for
the metabolism of various sphingolipids subspecies. There are three major pathways of ceramide synthesis.
In de novo synthesis pathway ceramide is created from less complex molecules [4]. The second path is
catabolism of complex sphingolipids, mainly sphingomyelin [5]. Ceramide generation can also occur
through the breakdown of complex sphingolipids that are ultimately broken down into sphingosine in
acidic environment of lysosome. In this pathway, known as salvage pathway, sphingosine is then reused by
reacylation to form ceramide [6]. On the same time ceramide may serve as a substrate for the synthesis of
SM, C1P, and SPH which, in turns, can be phosphorylated to S1P [7–11]. For the long time these
molecules were considered to have mainly structural function, but only in the last two decades
sphingolipids were recognized as important messengers in cellular signalling pathways [12,13].
Notable body of work has been devoted studying the influence of sphingolipids metabolism on cellular fate
– autophagy, apoptosis, proliferation and differentiation [14,15]. Importantly, individual sphingolipid
species appear to have the opposite effect on cell growth and survival. Dynamic balance between
proapoptotic molecules (e.g. CER and SPH) and antiapoptotic – prosurvival ones (e.g. S1P and C1P) is
termed as sphingolipid rheostat [16]. Disruptions in metabolic pathways involved in controlling this balance
are considered to underlay various diseases. Indeed, sphingolipids are known to have critical implications
for the pathogenesis and treatment of such different illnesses like cancer [17–20] and neurodegenerative
disorders (e.g. Alzheimer’s disease) [21–25].
Related research. Formal modelling seems to be an excellent tool to predict the response of the systems in
different scenarios and to the wide range of both external and internal perturbations. However, due to the
complexity of sphingolipids metabolom, and the paucity of data, not much has been done in the field of
computational sphingolipidom modelling. There are only few models of SL metabolism available in the
literature. Provided by Vasquez et al. [26] model refers to de novo ceramide synthesis in yeast. It captures
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all essential elements of the ceramide synthesis from nonsphingolipid metabolites. However, no further
steps of ceramide and other more complex sphingolipids recycling (SM catabolic pathway and salvage
pathway) were taken into consideration.
The model proposed be Gupta et al. [27] describes the C16-branch of sphingolipid metabolism in
RAW264.7 cells. An advantage of this model is that it combines lipidomics and transcriptomics data
provided by the LIPID MAPS Consortium. However, the model is restricted to de closest metabolites of
C16 ceramide. Moreover none of the proposed models captured cell compartmental division, although it is
known that the ceramide metabolism differentiates among different cell compartments such as
mitochondria, nucleus and cell membrane. Therefore we found the construction of computational model for
the metabolism of complex sphingolipids in human tissues to be an appealing task.
Our results. We propose a formal model of regulatory processes capturing sphingolipid metabolism
pathways. Computational modelling is based on ordinary differential equations (ODEs) describing the
evolution of species concentration. Kinetics of the model is mostly based on the Mass Action Law (MAL)
for the molecular transportation reactions and the Michaelis-Menten (MM) approach for enzymatically
catalysed reactions. The modelled kinetics also covers the inhibition within competing species.
According to our best knowledge it is the first computational model of sphingolipid metabolism comprising
the compartmentalization based on typical structure of non-differentiated eukaryotic cell. Reactions
parameters were estimated basing on publicly available literature data and some default assumptions based
on experience with Biochemical Systems Theory (BST) [28], while the initial concentrations of particular
sphingolipd species in each organelle were taken from the LIPID MAPS database [29]. To validate our
model we applied both standard and novel methods of analysis i.e.: the local sensitivity analysis [30], the
variance decomposition [31] and the clustering of model’s parameters based on sensitivities clusters [32].
Finally we demonstrate the utility of our model to study the molecular events that are known to underly
Alzheimer’s disease (AD). The proposed model provides a comprehensive, functional integration of
experimental data, and we hope it will have significant implications for understanding of still not fully
elucidated dependence between sphingolipid metabolism and various diseases. Moreover for the first time
the two recently published methods of computational models analysis (i.e. variance decomposition [31] and
sensitivity clustering [32]) were applied to the medium size realistic biochemical model.
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2 Results and Discussion
2.1 Model of sphingolipids metabolism.
Our model captures all essential elements in the complex network of sphingolipids metabolism, except the
de novo synthesis of ceramide, which had been described by Vasquez et al. [26]. It illustrates the general
behaviour of chosen subspecies in non specified human tissue in 9 sub-cellular compartments representing
following organelle or their distinct parts:outer and inner layer of cell membrane, cytoplasm, endoplasmic
reticulum, cytoplasmatic and lumenal face of Golgi apparatus, nucleus, mitochondria and lysosome. Our
model includes 69 reactions of molecular transportation and biochemical transformation, see Figure 1.
Transportation
We applied Mass Action Law principle to describe transportation kinetics. Particular equations simulate
different ways of SL transportation, which are determined by specific biophysical properties of particular
sphingolipids [33]. It should be mentioned that most of these molecules (i.e. CER, SM, GSL) are restricted
to biological membranes. Their transportation between organelle is possible only in form of complexes with
lipid transfer proteins (LTP) [34] e.g. ceramide transfer protein (CERT) binds to CER. Additionally, they
might change their location in form of vesicles, as an integral part of biological membranes [35]. For
example translocation of SM and GSL from Golgi apparatus to outer membrane is correlated with
exocytosis, while during the endocytosis complex SL may get in to the lysosome. Sphingolipids may also
diffuse along the membranes between linked organelle, as it is in case of ceramide floating between
endoplasmic reticulum and nucleus [36]. On the other hand, SPH, S1P and C1P are enough hydrophilic to
diffuse freely from the membranes to the cytosol, likewise from the outer membrane to the external
environment [37]. Still, it was reported that transportation of C1P from the Golgi apparatus to other
cellular compartments may also occur in association with specific transporter proteins as
ceramide-1-phosphate transfer protein CPTP [38]. Water solubility also determines molecules ability to flip
between membrane leaflets. CER has relatively rapid flip rate, also SPH is sufficiently amphipathic to
move between membrane layers [39,40]. Finally S1P needs specific lipid transporters to traverse
membranes [41,42]. Similarly complex sphingolipids are unable to cross the membranes without the aid of
specific flippases like four-phosphate adaptor protein 2 FAPP2 puling GluCER from the outer to the inner
surface of Golgi cisterns [43].
5
Ceramide synthesis and degradation
Most of the reactions depicted in the diagram are enzymatic. Michaelis-Menten model (MM) and
simplified kinetics derived by the MM model was applied to describe different ways of synthesis and
degradation of chosen SL species. CER synthesis via de novo path is described as the inflow of these
molecule in endoplasmic reticulum. CER might be also generated by the acetylation of SPH. This reaction,
catalysed by different types of ceramide synhases (CerS) [44] is the final step of the salvage pathway [6].
Importantly endoplasmic SPH utilized in this path may becomes from degradation of S1P what is
catalysed by specific phospathases (SPP1 andSPP2 ) [45] or from lysosomal degradation of complex SL.
This later path initiated by acidic sphingomyelinase (aSMase)and known to be critical for the maintaining
proper concentrations of cellular SL [46,47]. In addition to described above endoplasmic route of CER
synthesis similar subset of reactions can be described for the mitochondria. Although, reactions of
mitochondrial SL metabolism are not fully understood yet. Especially enzymes specificity and values of
reaction rates parameters are often unknown [48,49]. The third way of CER synthesis is hydrolysis of SM.
SMases responsible for catalysing this reaction are classified in to three categories based on their pH
optima and sub-cellular distribution. Degradation of SM is known to be essential for the homeostasis of
cell membranes, it was also reported to be strongly related to the stress induced apoptosis [14,50,51].
Finally we described hydrolysis of CER.Catalysing this reaction ceramidases CDase, 7 of which are known
in human, cleave fatty acids from CER producing SPH [52].
Synthesis of complex SL
At the apex of SL complexity are sphingomyelins (SM) and even more diverse glycosphingolipids (GSL).
Even though some enzymes responsible for the synthesis of these complex SL were detected in e.g. nucleus
this pathway is mainly localized in the Golgi apparatus. In both cases CER is utilized as a backbone
molecule. However, whether it would be converted in to SM or GSL depends on the way of its
transportation from the endoplasmic reticulum. CER transported in the complex whit CERT protein gets
to the cis-Golgi where it gives rise to the SM in the SMS catalysed reaction [53,54]. While, to form GSL in
the series reactions CER must get to the trans-Golgi via vesicle dependent way [55].
S1P and C1P metabolism
Moreover our model includes reactions of CER and SPH phosphorylation, produced S1P and C1P, unlike
CER and SPH, promote cell growth and have anti-apoptotic properties [16,56]. The antagonistic effect of
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these metabolites is regulated by the activity of many enzymes: (i) ceramide kinase CERK responsible for
the synthesis of C1P in the Golgi apparatus and the plasma membrane [57], (ii) sphingosine kinases SK1
and SK2 catalysing phosphorylation of SPH in different subcellular locations [58,59] (iii) mentioned before
phosphatases able to hydrolyse S1P and C1P. Among them are both lipid phosphate phosphatases of broad
specificity (PAP2a, PAP2b and PAP2c) and S1P specific phosphatases (SPP1 and SPP2) [45,60]. All these
enzymes with their isoformes differ in the substrate specificity, optimum pH and sub-cellular localization.
Our model illustrates most of their known properties. For detailed characteristics see reviev articles [7–11].
Importantly both S1P and C1P has been identified as inhibitors of enzymes responsible for CER synthesis
like acidic sphingomyelinase (aSMase) and serine palmitoyltransferase (SPT), the key regulatory enzyme of
de novo synthesis pathway. This inhibitory activity was described in our model by the inhibitory kinetics,
for details see supplementary Table 1. Finally our model includes reaction of irreversible degradation of
S1P. Catalysed by sphingosine-1-phosphate lyase (SPL1) reaction of S1P hydrolysis to hexadecenal and
phosphoetanolamine allows removal of sphingoid base from the pool of SL metabolites [60,61].
Model parameters
To conclude the model consists of 39 variables representing molecular species concentrations (some of them
are the same compounds localized in different compartments see Figure 1). Metabolic reactions network
covers 69 biochemical enzymatic and transportation reactions among the reacting species. The model is
implemented in a form of a system of 69 ordinary differential equations (ODEs) modelling the reaction
network dynamics. Relevant input of the model are 129 parameters of inhibition and reactions rates in
stationary state representing homeostasis conditions presented in supplementary Table 1 as well as 38
initial values of species concentrations (supplementary Table 2). To achieve conditions resembling
intracellular environment during the homoeostasis we stabilize the species concentrations to the stationary
state of the system. Initial values for lipid levels were taken from the LIPID MAPS [26]. In the sequel, we
validate the model by performing local sensitivity analysis, variance decomposition and clustering analysis.
2.2 Computational validation of the model
Biochemical models are characterized by substantially larger number of parameters relative to data size.
Therefore the exact estimation of model parameters is very difficult to perform [62]. Thus we used
mathematical modelling to analyse the dependencies between parameters and model dynamics. To verify
assumptions of our model we applied several techniques to get the broad view of the modelled system
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behaviour under normal and stressed conditions. The validation techniques were based on recently
proposed and classical approaches engaging exact mathematical methods.
Local sensitivity analysis
The outcome of the local sensitivity analysis [30] performed for system in stationary state – homeostasis
(see Figure 2 and supplementary Figures 1-3) yielded the following conclusions.
The local sensitivity analysis of the ceramides species
Figure 2: The local sensitivity analysis of the CER species to the highly significant parameters.
• Within ceramide species the highest sensitivity indices were assigned to mitochondrial and lysosomal
CER according to ceramide shynthase (CerS) in mitochondrion and sphingomielynase (SMase) in
lysosome respectively. The highest variability present CER in endoplasmic reticulum mostly to the
model’s inflows parameters both the exogenous by outer membrane and endogenous by de novo
synthesis in endoplasmic reticulum. What is more unexpected CER in endoplasmic reticulum is also
highly sensitive to the parameter reaction catalysed by SMase in outer membrane. High sensitivity to
the parameters of exogenous inflow of CER and C1P show membrane CER species, which are also
sensitive to the membrane reactions catalysed by SMases (see Figure 2).
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• For the sphingosine species the greatest instability behaviour shows the mitochondrial SPH, that is
highly sensitive to the model’s inflows parameters as well as the parameter of reaction catalysed by
enzyme CerS in mitochondrion. Moreover mitochondrial SPH is sensitive to the SMase catalysed
reactions in membrane (see supplementary Figure 1). In contrary concentration of SPH localised in
cytozol is practically invariant to parameters.
• Mitochondrial S1P shows the greatest instability within the S1P species, not only for the model’s
inflows parameters and CerS in mitochondrion, but also for parameters of reactions catalysed by
SMase in membrane and lysosom. For the other S1P species the greatest significant is
sphingosinokinase in reticulum, inner membrane and nucleus respectively. Again the cytoplasmic S1P
is the most stable S1P species (see supplementary Figure 2).
• Sphingomyelin in outer membrane is the dominant species within all other species, consequently the
exogenous inflow of SM by outer membrane is the most significant parameter for the SM species.
Other surprising observation is that this parameter does not play noticeable role for all other species
that are sensitive for model’s inflows parameters by outer membrane (exogenous: C1P, CER, SPH,
S1P). Another interesting feature is that the nuclear SM is the most stable within SM species (see
supplementary Figure 3).
Variance decomposition – homeostasis
The variance decomposition method [31] enables to decompose noise – the uncertainty of the modelled
output into components seaming from different reactions [31,63]. This method applied to our model
principally indicate the reactions corresponding to edges in Figure 1 incident to investigated species as the
highest noise generators. Nevertheless some reactions were more significant for investigated species than
other incident reactions, whereas for some other species variance were distributed equally among all
reactions. To find the distinctive reactions we calculated the mean variance for each investigated species
and set the threshold to 110% of the mean variance. The results for CER species are depicted in Figure 3
and for SPH, S1P and SM is depicted in supplementary Figures 4-6, respectively.
• Within the ceramides species the highest variance shows the mitochondrial and lysosomal CER. For
CER the threshold set on 110% of average variance was exceeded only by the reactions catalysed by
ceramideshynthase (CerS) and acid ceramidase (ACDase) in mitochondrion. The membrane CER
species interact together so for inner membrane CER not only incident reactions exceeded the
9
The variance decomposition for the ceramides species
Figure 3: The variance decomposition of the ceramides concentration into components steaming from all
model reactions. The red lines denotes the averages variance components of the investigated species. The
red bars denotes the variance components that exceed the threshold of 110% of average. The x- axis denotes
reactions numbers, the y-axis denotes the size of variance components.
threshold but also reaction incident with outer membrane CER catalysed by aSMase. For the outer
membrane CER the highest variance component steams from the reactions incident with outer
membrane C1P and transportation reaction of C1P from Golgi apparatus to outer membrane. For
the other CER species the highest variance is caused by the incident reactions.
• Within the sphingosine species the highest variance similarly to CER species falls to the
mitochondrial SPH, whereas contrary to the mitochondrial CER for the mitochondrial SPH all
reactions’ noise components are near to the average. Interesting is that two incident reactions
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connecting mitochondrial SPH with mitochondrial CER exceeded threshold and two other incident
reactions connecting mitochondrial SPH with mitochondrial S1P are significantly below the average.
Similarly nuclear and endoplasmic SPH have high and almost equally distributed noise with most
significant incident reactions. For nuclear SPH the threshold was exceeded also by non-incident
reactions incident with nuclear CER. For the membrane SPH species highly influential reaction is the
SPH membrane diffusion. For the inner membrane SPH except the incident reactions the high noise
components steams from reactions connected with outer membrane CER (between outer membrane
SM and SPH). The outer membrane SPH significant reactions include transportation reaction of C1P
from Golgi apparatus to outer membrane and reactions connected with outer membrane CER and
outer membrane S1P. For the lysosomal SPH except incident reactions the high noise component
steams from reaction catalysed by aSMase in lysosome. For the cytoplasmic SPH except incident
reactions the threshold was exceeded by the reaction catalysed by AlkCDase in Golgi apparatus. For
Golgi apparatus SPH the noise was mainly decomposed by incident reactions.
• The highest variability within S1P species has the mitochondrial S1P. It’s all variance components
are near to average noise and non of the reactions exceed the threshold of 110%. Variance of all other
S1P species steams principally from the incident reactions with one exception of cytoplasmic S1P
which noise is generated mainly by lysosomal reaction catalysed by aSMase.
• The SM species have the highest noise among all species and contrary to most other species the
variance of SM species steams almost equally from all reactions.
Sensitivity based parameters clustering (homeostasis)
The complex structure of our model makes it the ideal candidate to test the applicability of new method to
detect the mutual relations between parameters via clustering of mutually compensative ones [32]. Usually
parameters sets are not pairwise independent and commonly a biochemical model is sensitive to the linear
combination of parameters, what makes them not identifiable [62,64].
Using sensitivity clustering of parameters (see Section Methods 4) we obtained the dendrogram with
unequivocal division on four clusters (see Figure 4). We can interpret the obtained clusters as specific
functional modules. Importantly, these results are compatible with theoretical compartments recognized by
Rao et al. [65], who presented sphingolipid metabolic pathway as a combination of following units: (i) C1
compartment represents the de novo biosynthesis of CER, (ii) C2 compartment depicting the conversion of
11
Parameters clustering based on sensitivities – homeostasis
Figure 4: (a) Dendrogram obtained by hierarchical clustering of parameters based on their functional re-
dundancy. Identifiability analysis yielded 37 non-identifiable parameters (marked in red). Correspondence
between labels and names of the parameters is given in supplementary materials. (b) Clusters of reactions
induced by the hierarchical grouping. Colors of connections between species are compatible with colors of
clusters in the dendrogram. Higher color intensity within the cluster means greater level of redundancy
between parameters of reaction and other parameters in the cluster.
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CER into complex sphingolipid like SM and GSL, (iii) C3 compartment represents hydrolysis of SM to
CER, (iv) C4 compartment depicting conversion of CER into bioactive molecules such as C1P and S1P.
Ceramide phosphorylation
The structure of our clusters could be summarized as follows: brown cluster joins reactions parameters
from endoplasmic reticulum, Golgi apparatus, nucleus and cytoplasm. Strong redundancy between
parameters reflects their functional correlation. This cluster is mostly related to the conversion of SPH to
S1P and backwards. Beyoned sphingolipids phosphorylation and dephosphorylation it also contains
reactions of sphingosine acetylation and reverse reaction – deacetylation of CER. To some extent it
corresponds to the C4 compartment described by Rao et al. [65]. However, our cluster does not include
reactions taking place in cell membrane, which are classified to the blue and green cluster. Instead, we
found reactiondepicting endogenous inflow of ceramide in endoplasmic reticulum (simulating the de novo
synthesis pathway) to be a part of brown cluster. It is worth mention that our analysis shows reactions in
endoplasmic reticulum to form functional unity with nuclear reactions. What makes sense as, membranes
of reticulum are structurally joined with the nuclear envelope.
Complex SL synthesis
Blue cluster contains reactions parameters related to molecular composition of outer membrane. As cell
membrane is the biggest reservoir of sphingolipids, especially complex sphingolipids like sphingomyelin and
glycosphingolipids this cluster strongly affects general sphingolipid balance in the cell. Reactions from the
pathway of CER production via SM hydrolysis, mentioned before, are localized in this cluster. This is
confirmed by local sensitivity analysis, as we can observe strong influence of reactioncatalysed by aSMase
in outer membrane to many modelled species. As a consequence the pathways responsible for complex
sphingolipids (SM and GSL) synthesis are localized in this cluster. These reactions the strongly affect
stability of endoplasmic CER and subsequently cytoplasmatic SPH. Blue cluster is comparable to the C2
compartment as denoted in [65] reflecting complex SL synthesis. However, extending the results
from [65]we have shown that it forms a functional unity with reactions of outer cell membrane.
Interestingly results of our simulations are consistent with literature reports as SM metabolism at the
plasma membrane is known to have strong implications for bioactive sphingolipids balance [66].
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Sphingolipds degradation
Yellow cluster is related to the degradation of complex sphingolipids in acidic environment of lysosome. It
includes the starting point of the salvage pathway – SM transportation and degradation in lysosome and to
some extent resembles the C3 compartment form [65]. According to the local sensitivity analysis two
reactions from this cluster representing transportation of SM from outer membrane to lysosome and
ceramide synthase from SM in lysosome may affect the concentration of different molecular species of the
model like lysosomal and outer membrane CER, SM and SPH, endoplasmic CER or mitochondrial S1P
and SPH. However, the strength of this influence is not very high. This finding can be explained by the
relatively low activity of lysosomal degradation pathway in cells developing in favourable conditions. It
should be mentioned that according to the clustering analysis, lysosome belongs to intersection of yellow
and blue clusters what seems biologically correct as this organelle links pathways of complex SL synthesis
and degradation.
Inner membrane balance
Black cluster reflects inner membrane molecular balance and contains reaction parameters which are not
mutually related with other compartments, but have specific effect on behavior of other pathways. For
instance this cluster contains reactioncatalysed by nSMase in inner membrane which, on the basis of local
sensitivity analysis, appears to have slight impact on the stability of both CER, SPH and S1P in the whole
model.
2.3 Application of the model: case study of Alzheimer’s disease
Our model implements not only functional integration of experimental data but may be also used for
computational verification of molecular changes known to cause various human diseases. In this study we
applied our model to answer the question whether changes in enzymatic activity described by [65] would
lead to predicted cell behaviour typical for Alzheimer’s disease (AD). In recent studies it became evident
that sphingolipids play important roles in trafficking and metabolism of AD related proteins. Thus, they
emerged to crucial molecules in etiology of AD [23,67]. This devastating neurodegenerative disorder is
characterized by the accumulation of intraneuronal and extracellular protein aggregates and progressive
synapse loss. Pathological hallmarks of AD are extracellular deposition of peptide termed β-amyliod (Aβ)
and neurofibrillary tangles. Inability to catabolize aggregates of abnormally folded Aβ leads to neuronal
degeneration and subsequent decline in cognitive processes. On the level of sphingolipids metabolism most
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frequently reported are ceramide accumulation in endoplasmic reticulum and lysosome and sphingosine
accumulation in cytoplasm accompanied by decreased level of cytoplasmatic S1P and C1P [21–25].
Computational simulation of Alzheimer’s disease
Aiming to simulate cell response to metabolic disturbances of SL pathway described in [65] we have
changed values of chosen reaction parameters for cell homoeostasis. For details see supplementary Table 3.
We have modified parameters corresponding to the ceramidase (CDase) activity as well as parameters
corresponding to sphingosine kinase (SK) and ceramide kinase (CERK) dynamics. Moreover due to
down-regulation of CERT expression we have inhibited transportation of CER to Golgi apparatus. On the
other hand ceramide de novo synthesis reflected by the inflow reactionof CER in endoplasmic reticulum
was up-regulated. To test the system response in a AD scenario we simulated the time evolution of species
concentrations.
Trajectories of species concentration - AD scenario
Figure 5: Time evolution of molar concentration for the following groups of species (dashed lines corre-
spond to homeostasis scenario, solid lines to AD scenario): (a) ceramides species; (b) sphingosine species;
(c) sphingosine-1-phosphate species; (d) species functionally related to AD.
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Preliminary simulations have shown, that when changes were limited to those described by Rao et al. [65]
some modelled species quickly diverged to infinity. Namely, we observed unexpected rapid cumulation of
SM in many cellular compartments (i.e. lysosome, outer membrane and endoplasmic reticulum). Another
unforeseen system behaviour was increased rate of CER to GSL conversion in Golgi Apparatus, followed by
accumulation of GSL. Since such events do not occur in AD cells, we suggested that, initially introduced
modifications should be accompanied by: (i)reduced transportation of CER to Golgi apparatus via CERT
independent pathway, (ii) increased activity of sphingomyelinases (SMase). We also introduced some minor
changes in SM transportation between compartments. Importantly our predictions were confirmed by the
literature, namely impaired SM metabolism is known to be linked with AD [68,69]. These findings
emphasize the predictive value of our model.
After these biologically justified modifications all our results were coherent with experimental data, namely
we observed cumulation of ceramides in cellular compartments, especially in endoplasmic reticulum (ER)
and lysosome, in comparison to the homoeostasis level [65, 67].
The model output for sphingosine species concentration showed the imitate drop of SPH species due to
CDase down regulation, but than cumulation of SPH species in all compartments as a consequence of the
increase of CER species concentration. We also recorded the decrease of S1P species concentration in the
AD scenario (see Figure 5).
Local sensitivity analysis for the AD scenario vs homeostasis
Application of the AD scenario yielded slight changes in parameters local sensitivities.
• For the CER species, in contrary to homoeostasis, the most sensitive become ceramides in nucleus
and endoplasmic reticulum, that are sensitive basically to endogenous CER in endoplasmic reticulum
and exogenous C1P, CER, SPH, S1P in outer membrane inflow parameters as well as nSMase
reaction rate in outer membrane.
• The S1P in cytosol becomes sensitive to the SK2 in cytosol, analogously S1P in inner membrane
becomes sensitive to SK1 in inner membrane and S1P in outer membrane is more sensitive to inflow
parameterof exogenous S1P in outer membrane. However the mitochondrial S1P becomes invariant
to parameters changes.
• SPH species remains largely unchanged with most sensitive mitochondrial S1P.
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• Similarly SM species show an unchanged sensitivity with the dominant species SM in outer
membrane most sensitive.
Parameters clustering in the AD scenario vs homeostasis
Clustering analysis of AD model resulted in new parameters dendrogram with only two clusters in
comparison to four clusters obtained in homoeostasis (see Figure 6 and compare to Figure 4). Clusters
distinguished in AD simulation can be described as follows.
Complex SL and GSL metabolom
Green cluster is grouping parameters strongly associated with complex sphingolipids and
glycosphingolipids metabolism. It comes out that changes of SM balance are of great importance for
cellular metabolism in AD. This cluster includes formation of ceremide on the pathway of SM hydrolysis,
catabolism of SM and GSL in lyzosom (salvage pathway). Similarly to results obtained in homoeostasis our
model confirms that hydrolysis of SM in cell membrane and lysosome strongly influences the level of
cytoplasmic SPH. This cluster also includes parameters related to the synthesis of GSL and SM in Golgi
apparatus. To conclude this cluster can be regard as a combination of green, yellow and a part of the blue
homeostatic cluster its formation can be explained by the growth of the importance of SM transportation
and degradation during neurodegeneration.
Ceramide synthesis and accumulation
Red cluster includes reactions mostly affected by the inflow of the ceramide from de novo synthesis
pathway. According to lit. [70] in AD endoplasmic accumulation of ceramide from this source is important
step in disease development. Clusters analysis confirmed strong correlation between de novo synthesis and
concentration of CER in endoplasmic reticulum and subsequently in mitochondrion, nucleus and also Golgi
apparatus.
3 Conclusions
In the present paper an original model for sphingolipid metabolism in non-specified human tissue was
proposed. To our best knowledge, it is the most comprehensive model so far and also the first one, that
explicitly comprises the compartmentalization. We managed to keep the balance between the complexity
and biological soundness of the model and its computational tractability.
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Parameters clustering based on sensitivities – AD scenario
Figure 6: (a) Dendrogram obtained for AD scenario by hierarchical clustering of parameters based on their
functional redundancy. Model contains 36 non-identifiable parameters. (b) Clusters of reactions induced by
the hierarchical grouping.
Our results demonstrate that the model is an excellent tool for predicting SL pathway reaction to
perturbation in activity of particular enzymes, as well as the up- or down-regulation of modeled species.
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Thus the model may perfectly be used to simulate molecular behavior in various scenarios as it was shown
in the case study of Altzheimer’s disease.
Moreover, the implementation of semi-independent compartments (and the transportation reactions for the
molecular species flow between them) allows for more subtle manipulations of the reaction parameters for
specific organelle. Finally our model enables not only the integration but also validation of experimental
data by verifying their cross-compliance in a complex network of interactions.
Last but not least, the computational validation of the model was performed by means of recently
proposed sophisticated approaches [31,32]. Mathematically elegant methods of variance decomposition and
sensitivity clustering of parameters revealed non-trivial biological outcomes. More importantly, at the same
time the application of above mentioned approaches to our model constituted the perfect validation of
their usefulness in realistic size problems.
4 Methods
All molecular reactions within a system of interacting species S1 . . . SN may be presented in the following
manner:
Rj : ν1jS1 + · · ·+ νNjSN
kj−→ ν1jS1 + · · ·+ νNjSN ,
where νnj and νnj denote amounts of molecules of n-th species that are respectively substrate and product
of this reaction and the coefficient kj denotes reaction rate (speed) of the reaction.
The Mass Action Law kinetics.
In case of non-enzymatic or transpiration kinetics we used the Mass Action Law (MAL) principle. The
time derivative of each species concentration is the sum of in- and out-fluxes of all neighbouring reactions.
Here the one reaction flux is equal kj [S1]
ν1j · · · · · [SN ]νNj . Hence the Ordinary Differential Equations
derived from the MAL can be expressed in the form:
d[Sn]
dt
=
R∑
j=1
snjkj [S1]
ν1j · · · · · [SN ]νNj n = 1 . . . N
where snj = νnj − νnj denotes a stoichiometric coefficient of n-th species in j-th reaction and [Sn] denotes
the concentration of n-th species.
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The Michaelis-Menten kinetics.
Most of the reactions depicted in the diagram 1 are enzymatic reactions. For this kind of reactions we used
Michaelis-Menten model (MM) and simplified kinetics derived by the MM model:
d[P ]
dt
=
Vmax[S]
Km + [S]
,
where P denotes reaction product, S denotes reaction substrate and Vmax, Km are constant reaction
parameters.
Ordinary Diferential Equations.
Equivalently the ODEs can be expressed in the matrix form:
dS(t)
dt
= Mv(S(t)),
where the system state is represented by the time dependent state vector S(t) of species concentration, M
denotes the stoichiometry matrix and v(S(t)) denotes a vector of reaction fluxes (in our model according to
MAL or MM kinetics including inhibition rates) [30].
4.1 Local Sensitivity Analysis
Local sensitivity analysis shows how the uncertainty of parameters of the model can influence the model
output. Sensitivity may be measured by monitoring changes in the output by e.g. partial derivatives of the
modelled species to the single parameters. This appears a logical approach as any change observed in the
output will unambiguously be due to the single variable changed. To compare the sensitivity of the model
to the single parameters one construct the sensitivity indices by time integration of partial derivatives:
sn,i =
∫ T
0
∣∣∣∣∂Sn(t)∂θi
∣∣∣∣
θ=θ0
dt
where Sn are different species concentrations, θ is the vector of parameters and θ0 is some fixed point in
parameters space.
4.2 Variance Decomposition
The deterministic approach that represents the mean behaviour of the system can also be generalized to a
stochastic mode by meaning of Stochastic Differential Equations (SDE), both of which can be represented
in a discrete Markov Chain or a continuous Markov Process. Below we sketch the method of variance
decomposition as presented in [31].
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Stochastic Differential Equations.
Modelling the system behaviour in a stochastic manner means the examination not only the evolution of
the average system state that represents one of possible trajectories, but examination of the evolution of
the probability distribution over all possible system states.
The most popular approach to describe discrete stochastic model of biochemical pathway is Chemical
Master Equation (Chapman-Kolmogorov equation of Markov chain modelling the evolution of the system):
pP (x, t)
dt
=
∑
j
aj(x−mj)P (x−mj , t)−
∑
j
aj(x)P (x, t),
where the system state is denoted by the vector X(t) ∈ NN of numbers of molecules each row for one of N
reacting species, mj denotes the j-th column of stoichiometry matrix M = (m1, . . . ,mR) and P (x, t)
denotes the time- and state-dependent distribution of system being in state X(t) = x and finally aj(X(t))
denotes the propensity function associated with the j-th reaction [30].
One of the possible simplification of the above equation is Linear Noise Approximation, where the dynamic
is modelled with Poisson process:
X(t) = X(0) +
R∑
j=1
mjNj
 t∫
0
fj(X(τ), τ)dτ

where Nj(X(t), t) denotes Poisson process dependent on time and a system state X(t), corresponding to
occurrence of j-th reaction. The probability that j-th reaction occur during the time interval [t; t+ dt)
equals fj(x, t)dt, where the fj(x, t) is called the transition rate.
Although accurate discrete models describe the exact evolution of probability distribution of the system
with the assumption that in one time point at most one reaction can occurre, they are computational not
efficient, as simulations require significant resources. Consequently it is more efficient to transit from
discrete to continuous process. Starting from deterministic approximation:
Φ(t) = Φ(0) +
R∑
j=1
mj
t∫
0
fj(Φ(s), s)ds
where Φ(t) is the mean system state being the solution of the ODEs one can describe the system state
evolution by dividing it into deterministic and stochastic part:
x(t) = ξ(t) + Φ(t)
where Φ(t) is the deterministic part and ξ(t) is the Winer process describing stochastic noise of a system
state [71]. The next step of stochastic noise decomposition is to divided noise linearly into noise steaming
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from separate reactions. The fact, that the total variance:
Σ(t) = 〈(x(t)− 〈x(t)〉)(x(t)− 〈x(t)〉)T 〉
is described by the differential equation
dΣ
dt
= A(t)Σ + ΣA(t)T +D(t), (1)
where
{A(Φ, t)}ik =
r∑
j=1
mij
∂fj(Φ, t)
∂Φk
and D(t) denotes diffusion matrix, can be represented as the sum of individual contributions,
Σ(t) = Σ(1)(t) + ... + Σ(r)(t). (2)
results directly from the decomposition of the diffusion matrix D(t) =
∑r
j=1D
(j)(t) and the linearity of the
equation for Σ(t). [31] By decomposing variance into the components from individual reactions, we are able
to determine the variability that the model has from each reaction, and therefore we are able to assess and
weigh the uncertainty of the model in division into single reactions.
4.3 Parameters clustering
In [32] the concept of functional redundancy has been proposed and used in hierarchical clustering
algorithm as dissimilarity measure. Let us define the model in Bayesian approach by the distribution of
data (X ∈ Rk) given parameters (θ ∈ Rl) as P (X|θ), together with a priori distribution P (θ). Assume that
θ = (θA, θB) corresponds to division of parameters on two independent sets then [72]:
H(X) = I(X, θA) + I(X, θB) + I(θA, θB |X) +H(X|θ), (3)
where H denotes here the entropy and I is the mutual information between random variables. Here
I(θA, θB |X) measures this part of entropy which is shared by both sets of parameters and it is equivalent
to redundant knowledge of the model which is owned by θA and θB .
Computation of I(θA, θB |X) requires calculation integral over all possible outcomes of the model what is
highly inefficient, hence, this notion has been replaced with local redundancy measure which substitute
assumption of knowledge about the model X with information about initial parameters θ∗. Thus,
functional redundancy is equal to I(θA, θB |θ∗) and is calculated according to the formul [73]:
I(θA, θB |θ∗) = −1
2
min(|θA|,|θB |)∑
i=1
log(1− ρ2j ), (4)
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where ρi stands for the canonical correlation obtained from the Fisher Information Matrix of θ
∗ (FIM(θ∗)).
Moreover, to indicate non-identifiable parameters authors define term of (δ, ζ) - identifiability using the
idea of functional redundancy [32]. In this terminology θi is (δ, ζ) - identifiable if FIMii(θ) > ζ and
ρ(θi, θ−i) < 1− δ, where θ−i represents all parameters except θi.
Using functional redundancy we can cluster parameters according to hierarchical algorithm (i.e. in every
turn of the loop we merge two sets of the parameters with the biggest redundancy measure and remove all
nonindentifiable parameters from further analysis) and visualize it on a dendrogram.
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Abbreviations
Abbreviation Meaning
ACDase Acidic Ceramidase.
AD Alzheimer’s Disease.
AlkCDase Alkaline Ceramidase.
aSMase Acid Sphingomyelinase.
BST Biochemical Systems Theory.
C1P Ceramide-1-Phosphate.
CDase Ceramidase.
CER Ceramide.
CERK Ceramide Kinase.
CerS Ceramide Synthase.
CERT Ceramide Transfer Protein.
CPTP Ceramide-1-Phosphate Transfer Protein.
ER Endoplasmatic Reticulum.
FAPP2 Four-Phosphate Adaptor Protein 2.
GluCER Glucosylceramide.
GSL Glycosphingolipid.
LTP Lipid-Transfer Proteins.
MAL Mass Action Law kinetics.
MM Michealis-Menten kinetics.
nSMase Neutral Sphingomyelinase.
ODEs Ordinary Differential Equations.
PAP2a Phosphatidic acid phosphatase type 2a.
PAP2b Phosphatidic acid phosphatase type 2b.
PAP2c Phosphatidic acid phosphatase type 2c.
S1P Sphingosine-1-Phosphate.
SDE Stochastic Differential Equations.
SK Sphingosine Kinase.
SK1 Sphingosine Kinase 1.
SK2 Sphingosine Kinase 2.
SL Sphingolipids.
SM Sphingomyelin.
SMase Sphingomyelinase.
SMS Sphingomyelin Synthase.
SPH Sphingosine.
SPL1 Sphingosine 1-Phosphate Lyase 1.
SPP1 Sphingosine-1-Phosphate Phosphatase 1.
SPP2 Sphingosine-1-Phosphate Phosphatase 2.
SPT Serine Palmitoyltransferase.
24
References
1. Thudichum JLW: A Treatise on the Chemical Constitution of Brain. London: Bailliere, Tindall, and Cox 1884.
2. Carter HE, Haines WJ: Biochemistry of the sphingolipides; preparation of sphingolipides from beef
brain and spinal cord. J. Biol. Chem. 1947, 169:77–82.
3. Pruett ST, Bushnev A, Hagedorn K, Adiga M, Haynes CA, Sullards MC, Liotta DC, Merrill AH: Biodiversity
of sphingoid bases (”sphingosines”) and related amino alcohols. J. Lipid Res. 2008, 49(8):1621–1639.
4. Merrill AH: De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem.
2002, 277(29):25843–25846.
5. Furst W, Sandhoff K: Activator proteins and topology of lysosomal sphingolipid catabolism.
Biochim. Biophys. Acta 1992, 1126:1–16.
6. Kitatani K, Idkowiak-Baldys J, Hannun YA: The sphingolipid salvage pathway in ceramide
metabolism and signaling. Cell. Signal. 2008, 20(6):1010–1018.
7. Kolter T, Proia RL, Sandhoff K: Combinatorial ganglioside biosynthesis. J. Biol. Chem. 2002,
277(29):25859–25862.
8. Hannun YA, Obeid LM: Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev.
Mol. Cell Biol. 2008, 9(2):139–150.
9. Gault CR, Obeid LM, Hannun YA: An overview of sphingolipid metabolism: from synthesis to
breakdown. Adv. Exp. Med. Biol. 2010, 688:1–23.
10. Bartke N, Hannun YA: Bioactive sphingolipids: metabolism and function. J. Lipid Res. 2009, 50
Suppl:S91–96.
11. Merrill AH: Sphingolipid and glycosphingolipid metabolic pathways in the era of
sphingolipidomics. Chem. Rev. 2011, 111(10):6387–6422.
12. Hannun YA, Loomis CR, Merrill AH, Bell RM: Sphingosine inhibition of protein kinase C activity and
of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 1986,
261(27):12604–12609.
13. Dressler KA, Mathias S, Kolesnick RN: Tumor necrosis factor-alpha activates the sphingomyelin
signal transduction pathway in a cell-free system. Science 1992, 255(5052):1715–1718.
14. Hannun YA: Functions of ceramide in coordinating cellular responses to stress. Science 1996,
274(5294):1855–1859.
15. Hannun YA, Obeid LM: The Ceramide-centric universe of lipid-mediated cell regulation: stress
encounters of the lipid kind. J. Biol. Chem. 2002, 277(29):25847–25850.
16. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of
ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996,
381(6585):800–803.
17. Ogretmen B, Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment.
Nat. Rev. Cancer 2004, 4(8):604–616.
18. Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, Salas A, Ogretmen B:
Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death
and drug resistance. Future Oncol 2010, 6(10):1603–1624.
19. Ryland LK, Fox TE, Liu X, Loughran TP, Kester M: Dysregulation of sphingolipid metabolism in
cancer. Cancer Biol. Ther. 2011, 11(2):138–149.
20. Beckham TH, Cheng JC, Marrison ST, Norris JS, Liu X: Interdiction of sphingolipid metabolism to
improve standard cancer therapies. Adv. Cancer Res. 2013, 117:1–36.
21. He X, Huang Y, Li B, Gong CX, Schuchman EH: Deregulation of sphingolipid metabolism in
Alzheimer’s disease. Neurobiol. Aging 2010, 31(3):398–408.
22. Haughey NJ, Bandaru VV, Bae M, Mattson MP: Roles for dysfunctional sphingolipid metabolism in
Alzheimer’s disease neuropathogenesis. Biochim. Biophys. Acta 2010, 1801(8):878–886.
25
23. van Echten-Deckert G, Walter J: Sphingolipids: critical players in Alzheimer’s disease. Prog. Lipid Res.
2012, 51(4):378–393.
24. Grimm MO, Zimmer VC, Lehmann J, Grimm HS, Hartmann T: The impact of cholesterol, DHA, and
sphingolipids on Alzheimer’s disease. Biomed Res Int 2013, 2013:814390.
25. Ceccom J, Loukh N, Lauwers-Cances V, Touriol C, Nicaise Y, Gentil C, Uro-Coste E, Pitson S, Maurage CA,
Duyckaerts C, Cuvillier O, Delisle MB: Reduced sphingosine kinase-1 and enhanced sphingosine
1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in
Alzheimer’s disease. Acta Neuropathol Commun 2014, 2:12.
26. Alvarez-Vasquez F, Sims KJ, Cowart LA, Okamoto Y, Voit EO, Hannun YA: Simulation and validation of
modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 2005, 433(7024):425–430.
27. Gupta S, Maurya MR, Merrill AH, Glass CK, Subramaniam S: Integration of lipidomics and
transcriptomics data towards a systems biology model of sphingolipid metabolism. BMC Syst Biol
2011, 5:26.
28. Sorribas A, Savageau MA: Sphingolipid metabolic pathway: an overview of major roles played in
human diseases. Mathematical Biosciences 1989, 94(2):161–193.
29. LIPID MAPS Lipidomics Gateway [http://www.lipidmaps.org/].
30. Charzyn´ska A, Na lecz A, Rybin´ski M, Gambin A: Sensitivity analysis of mathematical models of
signaling pathways. BioTechnologia 2012, 93(3):291–30.
31. Komorowski M, Miekisz J, Stumpf M: Decomposing Noise in Biochemical Signalling Systems
Highlights the Role of Protein Degradation. Biophysical Journal 2013, 104(8):1783–1793.
32. W lodarczyk M, Lipniacki T, Komorowski M: Functional redundancy in the NF-κB signalling pathway
2013, [http://arxiv.org/abs/1303.3109]. [Manuscript submitted for publication].
33. Sonnino S, Prinetti A, Mauri L, Chigorno V, Tettamanti G: Dynamic and structural properties of
sphingolipids as driving forces for the formation of membrane domains. Chem. Rev. 2006,
106(6):2111–2125.
34. Lev S: Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat. Rev. Mol. Cell Biol.
2010, 11(10):739–750.
35. van Meer G, Lisman Q: Sphingolipid transport: rafts and translocators. J. Biol. Chem. 2002,
277(29):25855–25858.
36. Eggeling C, Ringemann C, Medda R, Schwarzmann G, Sandhoff K, Polyakova S, Belov VN, Hein B, von
Middendorff C, Schonle A, Hell SW: Direct observation of the nanoscale dynamics of membrane lipids
in a living cell. Nature 2009, 457(7233):1159–1162.
37. Tani M, Ito M, Igarashi Y: Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell
surface and in the extracellular space. Cell. Signal. 2007, 19(2):229–237.
38. Simanshu DK, Kamlekar RK, Wijesinghe DS, Zou X, Zhai X, Mishra SK, Molotkovsky JG, Malinina L,
Hinchcliffe EH, Chalfant CE, Brown RE, Patel DJ: Non-vesicular trafficking by a ceramide-1-phosphate
transfer protein regulates eicosanoids. Nature 2013, 500(7463):463–467.
39. Contreras FX, Basanez G, Alonso A, Herrmann A, Goni FM: Asymmetric addition of ceramides but not
dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys. J. 2005,
88:348–359.
40. van Meer G: Dynamic transbilayer lipid asymmetry. Cold Spring Harb Perspect Biol 2011, 3(5).
41. Kobayashi N, Kobayashi N, Yamaguchi A, Nishi T: Characterization of the ATP-dependent
sphingosine 1-phosphate transporter in rat erythrocytes. J. Biol. Chem. 2009, 284(32):21192–21200.
42. Aye IL, Singh AT, Keelan JA: Transport of lipids by ABC proteins: interactions and implications
for cellular toxicity, viability and function. Chem. Biol. Interact. 2009, 180(3):327–339.
43. D’Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A, Godi A, West G, Bielawski J, Chuang CC,
van der Spoel AC, Platt FM, Hannun YA, Polishchuk R, Mattjus P, De Matteis MA: Glycosphingolipid
synthesis requires FAPP2 transfer of glucosylceramide. Nature 2007, 449(7158):62–67.
26
44. Levy M, Futerman AH: Mammalian ceramide synthases. IUBMB Life 2010, 62(5):347–356.
45. Brindley DN: Lipid phosphate phosphatases and related proteins: signaling functions in
development, cell division, and cancer. J. Cell. Biochem. 2004, 92(5):900–912.
46. Jenkins RW, Canals D, Hannun YA: Roles and regulation of secretory and lysosomal acid
sphingomyelinase. Cell. Signal. 2009, 21(6):836–846.
47. Kolter T, Sandhoff K: Principles of lysosomal membrane digestion: stimulation of sphingolipid
degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev.
Biol. 2005, 21:81–103.
48. Siskind LJ: Mitochondrial ceramide and the induction of apoptosis. J. Bioenerg. Biomembr. 2005,
37(3):143–153.
49. Bionda C, Portoukalian J, Schmitt D, Rodriguez-Lafrasse C, Ardail D: Subcellular compartmentalization
of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?
Biochem. J. 2004, 382(Pt 2):527–533.
50. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman
EH, Fuks Z, Kolesnick R: Acid sphingomyelinase-deficient human lymphoblasts and mice are
defective in radiation-induced apoptosis. Cell 1996, 86(2):189–199.
51. Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelin pathway. Biochem.
Pharmacol. 1997, 53(5):615–621.
52. Mao C, Obeid LM: Ceramidases: regulators of cellular responses mediated by ceramide,
sphingosine, and sphingosine-1-phosphate. Biochim. Biophys. Acta 2008, 1781(9):424–434.
53. Merrill AH, Jones DD: An update of the enzymology and regulation of sphingomyelin metabolism.
Biochim. Biophys. Acta 1990, 1044:1–12.
54. Tafesse FG, Ternes P, Holthuis JC: The multigenic sphingomyelin synthase family. J. Biol. Chem. 2006,
281(40):29421–29425.
55. Funato K, Riezman H: Vesicular and nonvesicular transport of ceramide from ER to the Golgi
apparatus in yeast. J. Cell Biol. 2001, 155(6):949–959.
56. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of
ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996,
381(6585):800–803.
57. Sugiura M, Kono K, Liu H, Shimizugawa T, Minekura H, Spiegel S, Kohama T: Ceramide kinase, a novel
lipid kinase. Molecular cloning and functional characterization. J. Biol. Chem. 2002,
277(26):23294–23300.
58. Maceyka M, Payne SG, Milstien S, Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and
apoptosis. Biochim. Biophys. Acta 2002, 1585(2-3):193–201.
59. Pitson SM: Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem. Sci. 2011,
36(2):97–107.
60. Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol.
2003, 4(5):397–407.
61. Bourquin F, Riezman H, Capitani G, Grutter MG: Structure and function of sphingosine-1-phosphate
lyase, a key enzyme of sphingolipid metabolism. Structure 2010, 18(8):1054–1065.
62. Brown KS, Sethna JP: Statistical mechanical approaches to models with many poorly known
parameters. Physical Review E - PHYS REV E 2003, 68(2).
63. Jetka T, Charzyn´ska A, Gambin A, Stumpf MP, Komorowski M: StochDecomp - Matlab package for
noise decomposition in stochastic biochemical systems. Bioinformatics 2014, 30:137–138.
64. Lipniacki T, Paszek P, Brasier AR, Luxon B, Kimmel M: Mathematical model of NF-κB regulatory
module. Journal of theoretical biology 2004, 228(2):195–215.
65. Pralhada Rao R, Vaidyanathan N, Rengasamy M, Mammen Oommen A, Somaiya N, Jagannath MR:
Sphingolipid metabolic pathway: an overview of major roles played in human diseases. J Lipids
2013, 2013:178910.
27
66. Milhas D, Clarke CJ, Hannun YA: Sphingomyelin metabolism at the plasma membrane: implications
for bioactive sphingolipids. FEBS Lett. 2010, 584(9):1887–1894.
67. Di Paolo G, Kim TW: Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nat. Rev.
Neurosci. 2011, 12(5):284–296.
68. Jana A, Pahan K: Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via
neutral sphingomyelinase: implications for Alzheimer’s disease. J. Neurosci. 2010,
30(38):12676–12689.
69. Lee JK, Jin HK, Park MH, Kim BR, Lee PH, Nakauchi H, Carter JE, He X, Schuchman EH, Bae JS: Acid
sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in
Alzheimer’s disease. J. Exp. Med. 2014, 211(8):1551–1570.
70. Paschen W, Mengesdorf T: Endoplasmic reticulum stress response and neurodegeneration. Cell
Calcium 2005, 38(3-4):409–415.
71. Komorowski M, Finkenstadt B, Harper CV, Rand DA: Bayesian inference of biochemical kinetic
parameters using the linear noise approximation. BMC Bioinformatics 2009, 10:343.
72. Lu¨dtke N, Panzeri S, Brown M, Broomhead DS, Knowles J, Montemurro MA, Kell DB:
Information-theoretic sensitivity analysis: a general method for credit assignment in complex
networks. Journal of The Royal Society Interface 2008, 5(19):223–235.
73. Johnson R, Wichern D: Applied multivariate statistical analysis, volume 4. NJ: Prentice hall Englewood Cliffs
1992.
28
